Variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials
Albert Caramoy,1 Ludwig M Heindl2 1Eye Center Wolfsburg-Fallersleben, Wolfsburg, 2Department of Ophthalmology, University of Cologne, Cologne, Germany Aim: The aim was to study the variability of choroidal scleral interface (CSI) thickness in healthy subjects and its relevance for designing future...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5bf9f3cf260c46ab833ed43064306302 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5bf9f3cf260c46ab833ed43064306302 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5bf9f3cf260c46ab833ed430643063022021-12-02T00:37:00ZVariability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials1177-5483https://doaj.org/article/5bf9f3cf260c46ab833ed430643063022017-10-01T00:00:00Zhttps://www.dovepress.com/variability-of-choroidal-and-retinal-thicknesses-in-healthy-eyes-using-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Albert Caramoy,1 Ludwig M Heindl2 1Eye Center Wolfsburg-Fallersleben, Wolfsburg, 2Department of Ophthalmology, University of Cologne, Cologne, Germany Aim: The aim was to study the variability of choroidal scleral interface (CSI) thickness in healthy subjects and its relevance for designing future studies. Methods: A total of 123 volunteers were imaged using swept-source optical coherence tomography. Early treatment diabetic retinopathy grid was used. Results: Mean central retinal thickness was 285.85±14.53 µm and 287.18±12.93 µm, and mean central CSI thickness was 273.94±77.77 µm and 271.19±78.85 µm for the right and left eyes, respectively. Mean retinal and CSI thicknesses correlated negatively with age (p=0.023, r=–0.208 and p<0.0001, r=–0.426, respectively) and axial length (p=0.016, r=–0.220 and p<0.0001, r=–0.504, respectively). To detect a CSI change of at least 112 µm, a sample size of 11 or 36 per group is needed for a single- or double-arm study, respectively (α=0.05, power =0.90, no loss to follow-up, assuming standard deviation in future studies as 100 µm). Conclusion: Future clinical studies using CSI as end point are possible with regard to sample size needed. Keywords: swept-source optical coherence tomography, choroidal thickness, retinal thickness, clinical trialsCaramoy AHeindl LMDove Medical Pressarticleswept-source optical coherence tomographychoroidal thicknessretinal thicknessclinical trialsOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 1835-1839 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
swept-source optical coherence tomography choroidal thickness retinal thickness clinical trials Ophthalmology RE1-994 |
spellingShingle |
swept-source optical coherence tomography choroidal thickness retinal thickness clinical trials Ophthalmology RE1-994 Caramoy A Heindl LM Variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials |
description |
Albert Caramoy,1 Ludwig M Heindl2 1Eye Center Wolfsburg-Fallersleben, Wolfsburg, 2Department of Ophthalmology, University of Cologne, Cologne, Germany Aim: The aim was to study the variability of choroidal scleral interface (CSI) thickness in healthy subjects and its relevance for designing future studies. Methods: A total of 123 volunteers were imaged using swept-source optical coherence tomography. Early treatment diabetic retinopathy grid was used. Results: Mean central retinal thickness was 285.85±14.53 µm and 287.18±12.93 µm, and mean central CSI thickness was 273.94±77.77 µm and 271.19±78.85 µm for the right and left eyes, respectively. Mean retinal and CSI thicknesses correlated negatively with age (p=0.023, r=–0.208 and p<0.0001, r=–0.426, respectively) and axial length (p=0.016, r=–0.220 and p<0.0001, r=–0.504, respectively). To detect a CSI change of at least 112 µm, a sample size of 11 or 36 per group is needed for a single- or double-arm study, respectively (α=0.05, power =0.90, no loss to follow-up, assuming standard deviation in future studies as 100 µm). Conclusion: Future clinical studies using CSI as end point are possible with regard to sample size needed. Keywords: swept-source optical coherence tomography, choroidal thickness, retinal thickness, clinical trials |
format |
article |
author |
Caramoy A Heindl LM |
author_facet |
Caramoy A Heindl LM |
author_sort |
Caramoy A |
title |
Variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials |
title_short |
Variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials |
title_full |
Variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials |
title_fullStr |
Variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials |
title_full_unstemmed |
Variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials |
title_sort |
variability of choroidal and retinal thicknesses in healthy eyes using swept-source optical coherence tomography – implications for designing clinical trials |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/5bf9f3cf260c46ab833ed43064306302 |
work_keys_str_mv |
AT caramoya variabilityofchoroidalandretinalthicknessesinhealthyeyesusingsweptsourceopticalcoherencetomographyndashimplicationsfordesigningclinicaltrials AT heindllm variabilityofchoroidalandretinalthicknessesinhealthyeyesusingsweptsourceopticalcoherencetomographyndashimplicationsfordesigningclinicaltrials |
_version_ |
1718403621379375104 |